Clinical Trials Using Bcr-Abl Kinase Inhibitor K0706
Clinical trials are research studies that involve people. The clinical trials on this list are studying Bcr-Abl Kinase Inhibitor K0706. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment Refractory / Intolerant CML Failing ≥3 Prior CML Therapies
Phase 1 / 2 study to determine safety, tolerability, pharmacokinetics, and anti-leukemic activity of Vodobatinib (K0706) in treatment-refractory / intolerant CML
Location: 8 locations